PMID: 11920636Mar 29, 2002Paper

Inhibition of tumor growth by systemic treatment with thrombospondin-1 peptide mimetics

International Journal of Cancer. Journal International Du Cancer
Frank ReiherSteven C Campbell

Abstract

Many normal human cells produce thrombospondin-1 (TSP-1), a potent antiangiogenic protein that promotes vascular quiescence. In various organ systems, including the brain, breast and bladder and in fibroblasts, TSP-1 secretion is reduced during tumorigenesis, thereby allowing induction of the vigorous neovascularization required for tumor growth and metastasis. Full-length and short TSP-1-derived peptides inhibit angiogenesis by inducing endothelial cell apoptosis and thus disrupting the vasculature of the growing tumor. CD36 expressed on the surface of endothelial cells functions as the primary antiangiogenic receptor for TSP-1. A D-isoleucyl enantiomer of a TSP-1 heptapeptide specifically inhibits the proliferation and migration of capillary endothelial cells. DI-TSP, an approximately 1 kDa capped version of this peptide, is also antiangiogenic in vitro, with a specific activity approaching that of the 450 kDa parental molecule. Here, we show that DI-TSP delivered systemically dose-dependently inhibits the growth of murine melanoma metastases in syngeneic animals and that its more soluble isomer, DI-TSPa, similarly blocks the progression of primary human bladder tumors in an orthotopic model in immune-deficient mice. Like int...Continue Reading

References

Jan 3, 1991·The New England Journal of Medicine·N WeidnerJ Folkman
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Aug 1, 1972·The Journal of Experimental Medicine·M A GimbroneJ Folkman
Aug 12, 1971·The New England Journal of Medicine·J Folkman
Jan 1, 1994·Cold Spring Harbor Symposia on Quantitative Biology·K M DameronN Bouck
Dec 5, 1995·Biochemical and Biophysical Research Communications·O V VolpertN Bouck
Jan 5, 1996·The Journal of Biological Chemistry·A G GaoW A Frazier
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·S ParangiD Hanahan
Jan 1, 1996·Advances in Cancer Research·N BouckS C Hsu
Jan 1, 1997·CA: a Cancer Journal for Clinicians·S L ParkerP A Wingo
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P B VermeulenL Y Dirix
May 1, 1997·Cancer Genetics and Cytogenetics·E van den BergS Störkel
Aug 11, 1997·The Journal of Cell Biology·D W DawsonN P Bouck
Oct 6, 1997·The Journal of Peptide Research : Official Journal of the American Peptide Society·N H GuoD D Roberts
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·O V VolpertN P Bouck
Jun 17, 1998·International Journal of Cancer. Journal International Du Cancer·T Danielsen, E K Rofstad
Nov 14, 1998·Biochemical and Biophysical Research Communications·T BoehmJ Folkman
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·A W GriffioenG Groenewegen
Mar 20, 1999·The Journal of Biological Chemistry·W A FrazierM E Linder
Dec 2, 1999·Nature Medicine·N Ferrara, K Alitalo
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·M StreitM Detmar
Feb 26, 2000·Carcinogenesis·R S Kerbel
Mar 25, 2000·British Journal of Cancer·M K Oehler, R Bicknell
May 9, 2000·Critical Reviews in Oncology/hematology·M Hagedorn, A Bikfalvi
May 20, 2000·Advances in Cancer Research·J M CherringtonL K Shawver
Jun 15, 2000·The American Journal of Pathology·J KahnM E Gerritsen
Jul 7, 2000·British Journal of Cancer·A Compagni, G Christofori

❮ Previous
Next ❯

Citations

Apr 20, 2004·The International Journal of Biochemistry & Cell Biology·Jack Lawler, Michael Detmar
Apr 26, 2003·Matrix Biology : Journal of the International Society for Matrix Biology·Lucas C Armstrong, Paul Bornstein
May 9, 2012·Expert Reviews in Molecular Medicine·Debabrata Patra, Linda J Sandell
Aug 8, 2008·Expert Reviews in Molecular Medicine·Joshua C AndersonCandece L Gladson
Oct 13, 2006·Nature Reviews. Cancer·Francesco BertoliniRobert S Kerbel
Jun 17, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xuefeng ZhangJack Lawler
Jun 7, 2007·American Journal of Clinical Oncology·Svetomir N MarkovicEdward T Creagan
May 4, 2012·Cold Spring Harbor Perspectives in Medicine·Patrick R Lawler, Jack Lawler
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·M A Grant, R Kalluri
Jan 30, 2004·Journal of Gastroenterology and Hepatology·Yi XiaoHelmut Friess
Jul 24, 2012·Journal of Veterinary Internal Medicine·A I SahoraC Khanna
Feb 27, 2008·Biochemistry. Biokhimii︠a︡·C Guruvayoorappan, G Kuttan
Apr 16, 2009·Cancer Research·Bin RenRoya Khosravi-Far
Feb 8, 2005·BMC Evolutionary Biology·Ainsley C NicholsonErwin G Van Meir
Jun 8, 2010·Molecular Cancer·Alexandre ChlenskiSusan L Cohn
Oct 10, 2006·The AAPS Journal·Yingjuan LuEmanuela Sega
Oct 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·Guido BocciRobert S Kerbel
Dec 6, 2011·Expert Opinion on Therapeutic Targets·Jack Henkin, Olga V Volpert
Dec 13, 2005·Expert Review of Anticancer Therapy·Hashim Uddin AhmedHitendra R H Patel
Jun 4, 2004·Expert Opinion on Investigational Drugs·Nabil Saba, Fadlo Khuri
Jan 15, 2016·Advanced Drug Delivery Reviews·Andrew J Sawyer, Themis R Kyriakides
Aug 2, 2011·Translational Oncology·Lingna LiSteven R Pirie-Shepherd
Aug 26, 2011·The International Journal of Biochemistry & Cell Biology·Dorina BelottiGiulia Taraboletti
Jun 15, 2007·Microvascular Research·Xuefeng Zhang, Jack Lawler
Apr 25, 2009·International Journal of Cancer. Journal International Du Cancer·Salman M HyderJianbo Wu
Aug 30, 2008·Journal of Cellular Physiology·Tanya A RegeCandece L Gladson
Feb 20, 2010·The American Journal of Pathology·Philip A KlenoticRoy L Silverstein
Oct 12, 2004·Biochemical and Biophysical Research Communications·Luis F CongoteBernard F Gibbs
Jun 3, 2004·The Journal of Surgical Research·Roderich E Schwarz, Margaret A Schwarz
Apr 29, 2006·International Immunopharmacology·Sheng-Teng HuangJong-Hwei S Pang
Dec 27, 2005·International Journal of Radiation Oncology, Biology, Physics·Mijung Kwon, Steven K Libutti
Jan 13, 2006·Biochimica Et Biophysica Acta·Bin RenRoya Khosravi-Far
Jan 7, 2003·Hematology/oncology Clinics of North America·Kerim Kaban, Roy S Herbst
Sep 14, 2013·Critical Reviews in Oncology/hematology·Liang ChengShaobo Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.